Section 5. Breast: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes

Hiromitsu Jinno, Tadashi Ikeda, Akira Matsui, Yuukou Kitagawa, Masaki Kitajima, Hirofumi Fujii, Kayoko Nakamura, Atsushi Kubo

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Axillary lymph node dissection (ALND) in the treatment of breast cancer is essential for predicting the prognosis and regional control of the tumor. At the same time ALND is associated with pain, numbness and sometimes lymphedema. Sentinel lymph node biopsy (SLNB) is a potential alternative procedure to conventional ALND in clinically node-negative breast cancer. In this study, we prepared the technetium-99m-labeled tin colloids with different sizes and compared their efficacy in SLNB. From September 1998 to February 2002, 184 clinically node-negative breast cancer patients were enrolled in the study at Keio University Hospital. Sentinel lymph nodes (SLNs) were identified by both blue dye and radioisotope. We prepared small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter). Regular-sized technetium-99m-labeled tin colloid is 400-1000 nm in diameter. In 74 patients, a SLNB was performed using regular-sized tin colloid; small-sized tin colloid was used in 110 patients. Subsequently, all of the patients were immediately followed by ALND. All dissected lymph nodes were evaluated by routine histopathological examination. The clinicopathological characteristics of the two groups were comparable. The lymphoscintigram detected SLN more frequently in the small-sized colloid group than in the regular-sized colloid group (P < 0.01). Small-sized tin colloid was also superior to regular-sized tin colloid in the SLN identification rate (97.3% versus 86.5%; P = 0.01). The mean value for ex vivo counts of the hottest sentinel lymph nodes of the small-sized colloid group was significantly higher than the counts of the regular-sized colloid group (P < 0.01). There was no significant difference in the accuracy between the two groups. It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid.

Original languageEnglish
JournalBiomedicine and Pharmacotherapy
Volume56
Issue numberSUPPL. 1
Publication statusPublished - 2002 Nov

Fingerprint

Sentinel Lymph Node Biopsy
Technetium
Colloids
Breast
Tin
Breast Neoplasms
Lymph Node Excision
technetium Tc 99m tin colloid
Lymphedema
Hypesthesia
Particle Size
Radioisotopes

Keywords

  • Breast cancer
  • Sentinel lymph node
  • Tin colloid

ASJC Scopus subject areas

  • Pharmacology

Cite this

Section 5. Breast : Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes. / Jinno, Hiromitsu; Ikeda, Tadashi; Matsui, Akira; Kitagawa, Yuukou; Kitajima, Masaki; Fujii, Hirofumi; Nakamura, Kayoko; Kubo, Atsushi.

In: Biomedicine and Pharmacotherapy, Vol. 56, No. SUPPL. 1, 11.2002.

Research output: Contribution to journalArticle

Jinno, H, Ikeda, T, Matsui, A, Kitagawa, Y, Kitajima, M, Fujii, H, Nakamura, K & Kubo, A 2002, 'Section 5. Breast: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes', Biomedicine and Pharmacotherapy, vol. 56, no. SUPPL. 1.
Jinno, Hiromitsu ; Ikeda, Tadashi ; Matsui, Akira ; Kitagawa, Yuukou ; Kitajima, Masaki ; Fujii, Hirofumi ; Nakamura, Kayoko ; Kubo, Atsushi. / Section 5. Breast : Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes. In: Biomedicine and Pharmacotherapy. 2002 ; Vol. 56, No. SUPPL. 1.
@article{dc177d6b2f924269901b0b33842cae22,
title = "Section 5. Breast: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes",
abstract = "Axillary lymph node dissection (ALND) in the treatment of breast cancer is essential for predicting the prognosis and regional control of the tumor. At the same time ALND is associated with pain, numbness and sometimes lymphedema. Sentinel lymph node biopsy (SLNB) is a potential alternative procedure to conventional ALND in clinically node-negative breast cancer. In this study, we prepared the technetium-99m-labeled tin colloids with different sizes and compared their efficacy in SLNB. From September 1998 to February 2002, 184 clinically node-negative breast cancer patients were enrolled in the study at Keio University Hospital. Sentinel lymph nodes (SLNs) were identified by both blue dye and radioisotope. We prepared small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter). Regular-sized technetium-99m-labeled tin colloid is 400-1000 nm in diameter. In 74 patients, a SLNB was performed using regular-sized tin colloid; small-sized tin colloid was used in 110 patients. Subsequently, all of the patients were immediately followed by ALND. All dissected lymph nodes were evaluated by routine histopathological examination. The clinicopathological characteristics of the two groups were comparable. The lymphoscintigram detected SLN more frequently in the small-sized colloid group than in the regular-sized colloid group (P < 0.01). Small-sized tin colloid was also superior to regular-sized tin colloid in the SLN identification rate (97.3{\%} versus 86.5{\%}; P = 0.01). The mean value for ex vivo counts of the hottest sentinel lymph nodes of the small-sized colloid group was significantly higher than the counts of the regular-sized colloid group (P < 0.01). There was no significant difference in the accuracy between the two groups. It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid.",
keywords = "Breast cancer, Sentinel lymph node, Tin colloid",
author = "Hiromitsu Jinno and Tadashi Ikeda and Akira Matsui and Yuukou Kitagawa and Masaki Kitajima and Hirofumi Fujii and Kayoko Nakamura and Atsushi Kubo",
year = "2002",
month = "11",
language = "English",
volume = "56",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Section 5. Breast

T2 - Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes

AU - Jinno, Hiromitsu

AU - Ikeda, Tadashi

AU - Matsui, Akira

AU - Kitagawa, Yuukou

AU - Kitajima, Masaki

AU - Fujii, Hirofumi

AU - Nakamura, Kayoko

AU - Kubo, Atsushi

PY - 2002/11

Y1 - 2002/11

N2 - Axillary lymph node dissection (ALND) in the treatment of breast cancer is essential for predicting the prognosis and regional control of the tumor. At the same time ALND is associated with pain, numbness and sometimes lymphedema. Sentinel lymph node biopsy (SLNB) is a potential alternative procedure to conventional ALND in clinically node-negative breast cancer. In this study, we prepared the technetium-99m-labeled tin colloids with different sizes and compared their efficacy in SLNB. From September 1998 to February 2002, 184 clinically node-negative breast cancer patients were enrolled in the study at Keio University Hospital. Sentinel lymph nodes (SLNs) were identified by both blue dye and radioisotope. We prepared small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter). Regular-sized technetium-99m-labeled tin colloid is 400-1000 nm in diameter. In 74 patients, a SLNB was performed using regular-sized tin colloid; small-sized tin colloid was used in 110 patients. Subsequently, all of the patients were immediately followed by ALND. All dissected lymph nodes were evaluated by routine histopathological examination. The clinicopathological characteristics of the two groups were comparable. The lymphoscintigram detected SLN more frequently in the small-sized colloid group than in the regular-sized colloid group (P < 0.01). Small-sized tin colloid was also superior to regular-sized tin colloid in the SLN identification rate (97.3% versus 86.5%; P = 0.01). The mean value for ex vivo counts of the hottest sentinel lymph nodes of the small-sized colloid group was significantly higher than the counts of the regular-sized colloid group (P < 0.01). There was no significant difference in the accuracy between the two groups. It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid.

AB - Axillary lymph node dissection (ALND) in the treatment of breast cancer is essential for predicting the prognosis and regional control of the tumor. At the same time ALND is associated with pain, numbness and sometimes lymphedema. Sentinel lymph node biopsy (SLNB) is a potential alternative procedure to conventional ALND in clinically node-negative breast cancer. In this study, we prepared the technetium-99m-labeled tin colloids with different sizes and compared their efficacy in SLNB. From September 1998 to February 2002, 184 clinically node-negative breast cancer patients were enrolled in the study at Keio University Hospital. Sentinel lymph nodes (SLNs) were identified by both blue dye and radioisotope. We prepared small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter). Regular-sized technetium-99m-labeled tin colloid is 400-1000 nm in diameter. In 74 patients, a SLNB was performed using regular-sized tin colloid; small-sized tin colloid was used in 110 patients. Subsequently, all of the patients were immediately followed by ALND. All dissected lymph nodes were evaluated by routine histopathological examination. The clinicopathological characteristics of the two groups were comparable. The lymphoscintigram detected SLN more frequently in the small-sized colloid group than in the regular-sized colloid group (P < 0.01). Small-sized tin colloid was also superior to regular-sized tin colloid in the SLN identification rate (97.3% versus 86.5%; P = 0.01). The mean value for ex vivo counts of the hottest sentinel lymph nodes of the small-sized colloid group was significantly higher than the counts of the regular-sized colloid group (P < 0.01). There was no significant difference in the accuracy between the two groups. It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid.

KW - Breast cancer

KW - Sentinel lymph node

KW - Tin colloid

UR - http://www.scopus.com/inward/record.url?scp=1842865327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842865327&partnerID=8YFLogxK

M3 - Article

C2 - 12487285

AN - SCOPUS:1842865327

VL - 56

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - SUPPL. 1

ER -